Sign In
Buy IBB
$178.09
+1.09 (+0.616%)
At Close: Jun 23, 2026
Biotech's Silent Resurgence (5-Year Base Breakout)
05:21pm, Tuesday, 23'rd Jun 2026
The biotech sector's fundamentals are shifting rapidly-and the smartest money on Wall Street is already quietly rotating into the sector.
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A
04:34pm, Tuesday, 23'rd Jun 2026
The biotechnology sector has broken out of its multiyear bear market. As macroeconomic headwinds moderate and regulatory environments stabilize, biotech ETFs are surging.
Chip Bloodbath Hits Nasdaq 100 As South Korea Plunges: Stock Market Today
12:45pm, Tuesday, 23'rd Jun 2026
U.S. stocks splintered Tuesday as a violent global sell-off in semiconductor shares hammered the Nasdaq, even as a rotation into defensive sectors and small caps kept the Dow Jones in positive territo
Should You Invest in the iShares Biotechnology ETF (IBB)?
07:20am, Monday, 22'nd Jun 2026
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on Febru
Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
01:00am, Tuesday, 16'th Jun 2026
Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-trac
IBB: Space Stocks And AI Stealing The Risk-On Show In 2026
03:52pm, Monday, 15'th Jun 2026
I reiterate a Hold rating on the iShares Nasdaq Biotechnology ETF, citing modest valuation but lackluster momentum and unfavorable market themes. IBB lags the S&P 500 YTD and faces headwinds as specul
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
07:14am, Thursday, 11'th Jun 2026
With AI and space dominating many of the market's most popular investment themes, it can be difficult to find differentiated opportunities. Healthcare is often viewed as one of the more defensive sect
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
01:01pm, Wednesday, 10'th Jun 2026
GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.
LONDON--(BUSINESS WIRE)---- $IBB #AVLSOM3--AV Laboratories, a science-led skincare company founded by pioneers in IVF solutions, regenerative medicine, and stem cell therapy, today announced it will e
Biotech Investors Are Tuning Out the MAHA Chaos
05:30am, Wednesday, 20'th May 2026
The Food and Drug Administration is still in turmoil, but Wall Street no longer cares.
Locking In A Quick Gain In This Biotech ETF Made Room For Better Swing Trades; Here's Why
03:08pm, Friday, 01'st May 2026
Locking in profits while you have them can help avoid downturns.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
07:21am, Thursday, 30'th Apr 2026
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund lau
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:20am, Tuesday, 28'th Apr 2026
The iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now
01:22pm, Thursday, 23'rd Apr 2026
Biotech has reasserted itself over the past year as drug approvals,
Kopp Family Office Trims $3.5 Million Worth of Viridian Therapeutics Stake -- What Investors Should Know
03:26pm, Tuesday, 21'st Apr 2026
Viridian Therapeutics is a clinical-stage biotech awaiting an FDA decision on its lead thyroid eye disease therapy.
